Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Just noticed something interesting about medical stocks this year - some are really standing out from the crowd. I was checking BTSG's performance and it's up 12% year-to-date, which is solid compared to the average medical stocks return of around 1%. That's a pretty decent spread.
What caught my attention is that BTSG has a strong analyst sentiment behind it. The earnings estimates have been revised upward by over 8% in the last quarter, which usually means more positive momentum ahead. Meanwhile, there's another medical stock worth watching - CCCC is up nearly 62% year-to-date, though it's in a different subsector. Both have solid rankings from the major research platforms.
If you're looking at medical stocks right now, these two seem to be the ones beating their peers. BTSG is outperforming its own industry group, which is down about 3% overall this year. It's one of those situations where you want to follow the stocks that are actually gaining ground while their sector struggles. Might be worth keeping these on your watchlist if you're building a medical stocks position.